3D-Printed Grafts for Knee Cartilage Repair
3D-PR-PBG
A Study on 3D Printing-assisted Platelet-rich Plasma Combined With Autologous Periosteum-bone Grafting in the Treatment of Knee Cartilage Injury
1 other identifier
interventional
60
1 country
1
Brief Summary
Research Title:A study on 3D printing-assisted platelet-rich plasma combined with autologous periosteum-bone grafting in the treatment of knee cartilage injury Objectives:(1) To evaluate the accuracy of cartilage damage repair by measuring the chimerism and surface curvature matching degree of 3D printing reconstruction. (2) 3D printing assisted platelerichplasma (PRP) combined with autologous periosteumBone grafting in patients with knee cartilage injury was evaluated for functional and imaging scores to evaluate the clinical effect and cartilage repair effect. Design Type:Prospective randomized controlled trial Research Objects:Unilateral knee cartilage injury area\>2CM2, international cartilagerepair society (ICRS) grade 3-4 patients Sample size: 60 cases (30 patients with 3D printing-assisted autologous periosteum-bone grafting, 3D printing-assisted PRP combined with autologous periosteum.) - 30 patients with bone grafting).Selection Criteria:(1) Age 18\~65 years old; (2) The body mass index (BMI) is 18\~30kg/m2 ; (3) Knee cartilage injury confirmed by imaging examination, knee cartilage injury 2\>cm2, ICRS grade 3-4; (4) There is no obvious abnormality in the lower limb force line; (5) No other drug injection or surgical treatment has been performed locally in the knee joint in the past 1 year. Observation indicators:(1) Clinical function(2) Imaging evaluation: Bilateral knee MRI examination was performed on the second day after surgery Statistical analysis methods:SPSS software was used for data analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2025
CompletedFirst Submitted
Initial submission to the registry
November 16, 2025
CompletedFirst Posted
Study publicly available on registry
December 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2029
December 31, 2025
August 1, 2025
4.4 years
November 16, 2025
December 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical function
(1) Clinical function: Knee joint obtained by outpatient follow-up, written questionnaires, or by telephone by trained medical professionals before surgery and 1, 3, 6, and 12 months after surgery Lysholm score, Tegner exercise ability score, and pain numeric score were used to assess the improvement of symptoms and function.Lysholm score:minimum:0,maximum:80,a higher score represents a better outcome;Tegner exercise ability score:minimum:0,maximum:80,a higher score represents a better outcome;pain numeric score:minimum:0,maximum:10,a higher score represents a worse outcome.)
1 year
Secondary Outcomes (1)
Imaging evaluation
1 year
Study Arms (2)
3D-Printed Scaffold-Assisted PRP Combined with Autologous Periosteal-Bone Grafting
EXPERIMENTAL3D-Printed Scaffold-Assisted PRP Combined with Autologous Periosteal-Bone Grafting
3D Printing-Assisted Autologous Periosteal-Bone Grafting
OTHER3D Printing-Assisted Autologous Periosteal-Bone Grafting
Interventions
3D-Printed Scaffold-Assisted PRP Combined with Autologous Periosteal-Bone Grafting
3D Printing-Assisted Autologous Periosteal-Bone Grafting
Eligibility Criteria
You may qualify if:
- Age 18-65 years;
- Body Mass Index (BMI) 18-30 kg/m²;
- Imaging-confirmed knee cartilage damage \>2 cm² with International Cartilage Repair Society (ICRS) grade 4;
- No significant lower limb alignment abnormalities;
- No prior local drug injections in the knee joint within the past year.
You may not qualify if:
- Significant osteoporosis;
- Individuals with immature bones;
- Those with poor mechanical alignment;
- Presence of meniscus injury, cruciate ligament or collateral ligament rupture, or incomplete healing following surgery for any of these conditions;
- Severe knee joint effusion;
- Use of corticosteroids or immunosuppressive agents;
- Poor general health, alcoholism, or substance abuse;
- Previous treatment with autologous blood products or stem cell preparations.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
330006
Nanchang, Jiangxi, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 16, 2025
First Posted
December 31, 2025
Study Start
August 1, 2025
Primary Completion (Estimated)
December 30, 2029
Study Completion (Estimated)
December 30, 2029
Last Updated
December 31, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share